In vitro antitumour activity given as IC50 ± S.D. in µM of the complexes 1–3 and cisplatin.

In vitro antiproliferative activity (IC50, μM) against three human tumor cell lines.

Dong-Dong Li (440627)
Ya-Juan Qin (440628)
Jian Sun (27858)
Jing-Ran Li (440629)
Fei Fang (64051)
Qian-Ru Du (440630)
Yong Qian (2377)
Hai-Bin Gong (440631)
Hai-Liang Zhu (439337)

August 2013

aAntiproliferative activity was measured using the WST-1 assay. Values are the average of two ind...

Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability-6

Alessandra Verdina (96033)
Irene Cardillo (96034)
Angela Nebbioso (96035)
Rossella Galati (96036)
Simona Menegozzo (96037)
Lucia Altucci (96038)
Ada Sacchi (85367)
Alfonso Baldi (82035)

December 2011

Ed by cell counts and was expressed as percent of control (untreated cells). Experiments were repeat...

Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability-0

Alessandra Verdina (96033)
Irene Cardillo (96034)
Angela Nebbioso (96035)
Rossella Galati (96036)
Simona Menegozzo (96037)
Lucia Altucci (96038)
Ada Sacchi (85367)
Alfonso Baldi (82035)

December 2011

Ed by cell counts and was expressed as percent of control (untreated cells). Experiments were repeat...

The results of in vitro cytotoxicity of complexes1–5 and cisplatin against variety of human cancer and healthy cell lines.

Ján Vančo (490366)
Jana Gáliková (644973)
Jan Hošek (490365)
Zdeněk Dvořák (3374294)
Lenka Paráková (490368)
Zdeněk Trávníček (490369)

October 2014

Cells were treated with the tested compounds for 24 h; measurements were performed in triplicate,...

The results of in

Radka Křikavová (630135)
Jan Hošek (490365)
Ján Vančo (490366)
Jakub Hutyra (630136)
Zdeněk Dvořák (3374294)
Zdeněk Trávníček (490369)

September 2014

vitro cytotoxicity against selected cancer cell lines for complexes 4–6 and </b...

The in vitro antitumour activity testing results.

Pavel Štarha (490367)
Jan Hošek (490365)
Ján Vančo (490366)
Zdeněk Dvořák (3374294)
Pavel Suchý Jr (531728)
Igor Popa (531729)
Gabriela Pražanová (531730)
Zdeněk Trávníček (490369)

March 2014

The data were obtained by the MTT assay against human lung carcinoma A549, cervix epithelial carc...

In vitro antitumor activity of 1–6, cisplatin and carboplatin against A2780, LNCaP and PC-3 cancer cell lines.

Pavel Štarha (490367)
Zdeněk Trávníček (490369)
Zdeněk Dvořák (3374294)
Tereza Radošová-Muchová (724315)
Jitka Prachařová (724316)
Ján Vančo (490366)
Jana Kašpárková (5663146)

April 2015

The results of the in vitro antitumor activity testing of 1–6, cisplatin<...

Cytotoxic activity of the complexes 2–5.

Pavel Štarha (490367)
Zdeněk Trávníček (490369)
Zdeněk Dvořák (3374294)
Tereza Radošová-Muchová (724315)
Jitka Prachařová (724316)
Ján Vančo (490366)
Jana Kašpárková (5663146)

April 2015

Cytotoxic activity of 2–5 at their 10 μM concentrations against the A2780 (top pane...

H-4073 and cisplatin treatment significantly inhibits STAT3 phosphorylation and markedly increases tumor cell apoptosis, in vivo.

Bhavna Kumar (18984)
Arti Yadav (162897)
Kalman Hideg (5658676)
Periannan Kuppusamy (43519)
Theodoros N. Teknos (162909)
Pawan Kumar (162916)

March 2014

A–D: Paraffin-embedded UM-SCC-74A tumor samples were stained for pSTAT3 (Y705) and ...

Cytotoxic effects of complexes on cells.

Shuo Shi (502857)
Shane Gao (502858)
Tongcheng Cao (502859)
Jie Liu (15128)
Xing Gao (112909)
Jian Hao (160736)
Chunyan Lv (502860)
Hailiang Huang (211727)
Jun Xu (45543)
Tianming Yao (502861)

December 2013

MTT assay was performed on human normal fibroblast cells treated with [(dmb)2Ru(obip)R...

H-4073 and cisplatin combination treatment significantly inhibits tumor growth.

Bhavna Kumar (18984)
Arti Yadav (162897)
Kalman Hideg (5658676)
Periannan Kuppusamy (43519)
Theodoros N. Teknos (162909)
Pawan Kumar (162916)

March 2014

Animals bearing UM-SCC-74A, CAL27 and CAL27-CisR were treated with H-4073 (50 ppm) or cisplatin (...

Anti-cancer activity of the studied compounds (ND—not determined).

Anna Mrozek-Wilczkiewicz (645763)
Ewelina Spaczynska (5665930)
Katarzyna Malarz (829453)
Wioleta Cieslik (761402)
Marzena Rams-Baron (761399)
Vladimír Kryštof (2521318)
Robert Musiol (645764)

November 2015

Results are expressed as mean ± SD of at least three independent experiments. IC50 val...

In vitro antiproliferative potency (IC50-µM) of compounds 5a–r and the standard CA-4 against tumor cell lines and human lymphocytes.

Daniel Nascimento do Amaral (533055)
Bruno C. Cavalcanti (533056)
Daniel P. Bezerra (533057)
Paulo Michel P. Ferreira (533058)
Rosane de Paula Castro (533059)
José Ricardo Sabino (533060)
Camila Maria Longo Machado (533061)
Roger Chammas (147550)
Claudia Pessoa (533062)
Carlos M. R. Sant'Anna (533063)
Eliezer J. Barreiro (128883)
Lídia Moreira Lima (533064)

March 2014

In vitro antiproliferative potency (IC50-µM) of compounds 5a–r and the s...

Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cells

Boccarelli, Angelina
Giordano, D
Natile, Giovanni
Coluccia, Mauro

January 2006

In order to compare the mechanistic properties of the antitumour-active trans platinum complex trans...

Different inhibitory concentrations (IC) of cisplatin in HeLa, SiHa shREV3L cells and control cells.

Li Yang (6520)
Tingyan Shi (703918)
Fei Liu (21082)
Chunxia Ren (703919)
Ziliang Wang (482117)
Yingyi Li (703920)
Xiaoyu Tu (703921)
Gong Yang (216381)
Xi Cheng (296756)

March 2015

IC30, 30% inhibitory concentration of cisplatin; IC50, 50% inhibitory concentration of cisplatin;...

In vitro antiproliferative activity (IC50, μM) against three human tumor cell lines.

Dong-Dong Li (440627)
Ya-Juan Qin (440628)
Jian Sun (27858)
Jing-Ran Li (440629)
Fei Fang (64051)
Qian-Ru Du (440630)
Yong Qian (2377)
Hai-Bin Gong (440631)
Hai-Liang Zhu (439337)

August 2013

aAntiproliferative activity was measured using the WST-1 assay. Values are the average of two ind...

Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability-6

Alessandra Verdina (96033)
Irene Cardillo (96034)
Angela Nebbioso (96035)
Rossella Galati (96036)
Simona Menegozzo (96037)
Lucia Altucci (96038)
Ada Sacchi (85367)
Alfonso Baldi (82035)

December 2011

Ed by cell counts and was expressed as percent of control (untreated cells). Experiments were repeat...

Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability-0

Alessandra Verdina (96033)
Irene Cardillo (96034)
Angela Nebbioso (96035)
Rossella Galati (96036)
Simona Menegozzo (96037)
Lucia Altucci (96038)
Ada Sacchi (85367)
Alfonso Baldi (82035)

December 2011

Ed by cell counts and was expressed as percent of control (untreated cells). Experiments were repeat...

The results of in vitro cytotoxicity of complexes1–5 and cisplatin against variety of human cancer and healthy cell lines.

Ján Vančo (490366)
Jana Gáliková (644973)
Jan Hošek (490365)
Zdeněk Dvořák (3374294)
Lenka Paráková (490368)
Zdeněk Trávníček (490369)

October 2014

Cells were treated with the tested compounds for 24 h; measurements were performed in triplicate,...

The results of in

Radka Křikavová (630135)
Jan Hošek (490365)
Ján Vančo (490366)
Jakub Hutyra (630136)
Zdeněk Dvořák (3374294)
Zdeněk Trávníček (490369)

September 2014

vitro cytotoxicity against selected cancer cell lines for complexes 4–6 and </b...

The in vitro antitumour activity testing results.

Pavel Štarha (490367)
Jan Hošek (490365)
Ján Vančo (490366)
Zdeněk Dvořák (3374294)
Pavel Suchý Jr (531728)
Igor Popa (531729)
Gabriela Pražanová (531730)
Zdeněk Trávníček (490369)

March 2014

The data were obtained by the MTT assay against human lung carcinoma A549, cervix epithelial carc...

In vitro antitumor activity of 1–6, cisplatin and carboplatin against A2780, LNCaP and PC-3 cancer cell lines.

Pavel Štarha (490367)
Zdeněk Trávníček (490369)
Zdeněk Dvořák (3374294)
Tereza Radošová-Muchová (724315)
Jitka Prachařová (724316)
Ján Vančo (490366)
Jana Kašpárková (5663146)

April 2015

The results of the in vitro antitumor activity testing of 1–6, cisplatin<...

Cytotoxic activity of the complexes 2–5.

Pavel Štarha (490367)
Zdeněk Trávníček (490369)
Zdeněk Dvořák (3374294)
Tereza Radošová-Muchová (724315)
Jitka Prachařová (724316)
Ján Vančo (490366)
Jana Kašpárková (5663146)

April 2015

Cytotoxic activity of 2–5 at their 10 μM concentrations against the A2780 (top pane...

H-4073 and cisplatin treatment significantly inhibits STAT3 phosphorylation and markedly increases tumor cell apoptosis, in vivo.

Bhavna Kumar (18984)
Arti Yadav (162897)
Kalman Hideg (5658676)
Periannan Kuppusamy (43519)
Theodoros N. Teknos (162909)
Pawan Kumar (162916)

March 2014

A–D: Paraffin-embedded UM-SCC-74A tumor samples were stained for pSTAT3 (Y705) and ...

Cytotoxic effects of complexes on cells.

Shuo Shi (502857)
Shane Gao (502858)
Tongcheng Cao (502859)
Jie Liu (15128)
Xing Gao (112909)
Jian Hao (160736)
Chunyan Lv (502860)
Hailiang Huang (211727)
Jun Xu (45543)
Tianming Yao (502861)

December 2013

MTT assay was performed on human normal fibroblast cells treated with [(dmb)2Ru(obip)R...

H-4073 and cisplatin combination treatment significantly inhibits tumor growth.

Bhavna Kumar (18984)
Arti Yadav (162897)
Kalman Hideg (5658676)
Periannan Kuppusamy (43519)
Theodoros N. Teknos (162909)
Pawan Kumar (162916)

March 2014

Animals bearing UM-SCC-74A, CAL27 and CAL27-CisR were treated with H-4073 (50 ppm) or cisplatin (...

Anti-cancer activity of the studied compounds (ND—not determined).

Anna Mrozek-Wilczkiewicz (645763)
Ewelina Spaczynska (5665930)
Katarzyna Malarz (829453)
Wioleta Cieslik (761402)
Marzena Rams-Baron (761399)
Vladimír Kryštof (2521318)
Robert Musiol (645764)

November 2015

Results are expressed as mean ± SD of at least three independent experiments. IC50 val...

In vitro antiproliferative potency (IC50-µM) of compounds 5a–r and the standard CA-4 against tumor cell lines and human lymphocytes.

Daniel Nascimento do Amaral (533055)
Bruno C. Cavalcanti (533056)
Daniel P. Bezerra (533057)
Paulo Michel P. Ferreira (533058)
Rosane de Paula Castro (533059)
José Ricardo Sabino (533060)
Camila Maria Longo Machado (533061)
Roger Chammas (147550)
Claudia Pessoa (533062)
Carlos M. R. Sant'Anna (533063)
Eliezer J. Barreiro (128883)
Lídia Moreira Lima (533064)

March 2014

In vitro antiproliferative potency (IC50-µM) of compounds 5a–r and the s...

Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cells

Boccarelli, Angelina
Giordano, D
Natile, Giovanni
Coluccia, Mauro

January 2006

In order to compare the mechanistic properties of the antitumour-active trans platinum complex trans...

Different inhibitory concentrations (IC) of cisplatin in HeLa, SiHa shREV3L cells and control cells.

Li Yang (6520)
Tingyan Shi (703918)
Fei Liu (21082)
Chunxia Ren (703919)
Ziliang Wang (482117)
Yingyi Li (703920)
Xiaoyu Tu (703921)
Gong Yang (216381)
Xi Cheng (296756)

March 2015

IC30, 30% inhibitory concentration of cisplatin; IC50, 50% inhibitory concentration of cisplatin;...

In vitro antiproliferative activity (IC50, μM) against three human tumor cell lines.

Dong-Dong Li (440627)
Ya-Juan Qin (440628)
Jian Sun (27858)
Jing-Ran Li (440629)
Fei Fang (64051)
Qian-Ru Du (440630)
Yong Qian (2377)
Hai-Bin Gong (440631)
Hai-Liang Zhu (439337)

August 2013

aAntiproliferative activity was measured using the WST-1 assay. Values are the average of two ind...

Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability-6

Alessandra Verdina (96033)
Irene Cardillo (96034)
Angela Nebbioso (96035)
Rossella Galati (96036)
Simona Menegozzo (96037)
Lucia Altucci (96038)
Ada Sacchi (85367)
Alfonso Baldi (82035)

December 2011

Ed by cell counts and was expressed as percent of control (untreated cells). Experiments were repeat...

Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability-0

Alessandra Verdina (96033)
Irene Cardillo (96034)
Angela Nebbioso (96035)
Rossella Galati (96036)
Simona Menegozzo (96037)
Lucia Altucci (96038)
Ada Sacchi (85367)
Alfonso Baldi (82035)

December 2011

Ed by cell counts and was expressed as percent of control (untreated cells). Experiments were repeat...

<i>In vitro</i> antitumour activity given as IC<sub>50</sub> ± S.D. in µM of the complexes <b>1</b>–<b>3</b> and <i>cisplatin</i>.

Abstract

Extracted data

<i>In vitro</i> antitumour activity given as IC<sub>50</sub> ± S.D. in µM of the complexes <b>1</b>–<b>3</b> and <i>cisplatin</i>.

Abstract

Extracted data

Related items

Related items